There were 1,869 press releases posted in the last 24 hours and 308,380 in the last 365 days.

Hydroxychloroquine Market Report 2021-2026: Global Size, Share, Growth, Industry Trends and Forecast

Hydroxychloroquine Market

SHERIDAN, WY, UNITED STATES, June 21, 2022 / -- According to the latest report by IMARC Group, titled “Hydroxychloroquine Market Size: Global Industry Trends, Share, Opportunity and Forecast 2021-2026,”The global hydroxychloroquine market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to exhibit robust growth during 2021-2026.

Hydroxychloroquine is a chemotherapeutic agent or drug that is predominantly used for the treatment and prevention of malaria. It acts against the erythrocytic stage parasites and is mostly consumed in the form of an oral tablet. Hydroxychloroquine is available in several dosages, such as 200mg, 300mg, 400mg, etc. It proves useful in the treatment of numerous other illnesses, including rheumatoid arthritis, systemic lupus erythematosus, Q fever, Porphyria Cutanea Tarda (PCT), and is also being examined for the possible remedy of the COVID-19 disease. As a result, hydroxychloroquine is extensively used across various healthcare sectors, such as specialty drugs, pharmaceuticals, hospitals, etc.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Global Hydroxychloroquine Market Trends:

The growing prevalence of malaria and other chronic ailments, especially in developing and underdeveloped economies, is primarily driving the hydroxychloroquine market. Besides this, the expanding clinical trials conducted across countries to analyze the efficacy of the drug in treating the adult patients hospitalized, on account of the sudden outbreak of the COVID-19 pandemic, is acting as another significant growth-inducing factor. Moreover, the rising cases of several autoimmune diseases, including rheumatoid arthritis and lupus erythematosus, is positively influencing the market growth. In addition to this, the inflatingexpenditure aimed at improving the healthcare infrastructure and the launch of extensive research and development (R&D) activities in the field of medical sciences are expected to augment the hydroxychloroquine market in the coming years.

Request Free Sample Report:

Global Hydroxychloroquine Market 2021-2026 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Amneal Pharmaceuticals Inc., Cardinal Health Inc., Cipla Ltd., Ipca Laboratories Ltd., Laurus Labs, Lupin Limited, Mylan N.V., Novartis AG, Prasco Laboratories, Dr. Reddy’s Laboratories Ltd., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Torrent Pharma, Zydus Cadila, etc.

The report has segmented the market on the basis on type, region, distribution, application,grade and administration

Breakup by Dosage Type:

200 Mg
300 Mg
400 Mg

Breakup by Distribution:

Hospital Pharmacies
Retail Pharmacies

Breakup by Application:

Rheumatoid Arthritis
Lupus Erythematosus
Coronavirus (COVID-19)

Breakup by Grade:

USP Standards Grade
EP Standards Grade
Pharmaceutical Standards Grade

Breakup by Route of Administration:


Breakup by Region:

North America: (United States, Canada)
Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico, Others)
Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure:

If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

Market Performance (2015-2020)
Market Outlook (2021- 2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Other Report by IMARC Group:

Hormonal Contraceptive Market:

Microfluidics Market:

Spine Biologics Market:

Orthobiologics Market:

Enteric Softgel Capsules Market

Hematologic Malignancies Market:

Thyroid Function Test Market:

Live Cell Imaging Market:

Inhaled Nitric Oxide Market:

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
+1 6317911145
email us here